Home›Search›Journal of Immunotherapy and Precision Oncology

Journal of Immunotherapy and Precision Oncology

Innovative Healthcare Institute · United States · Est. 2008

ISSN2666-2345eISSN2590-017X

SJR Q1✓ WOS ESCI✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

Medium Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q1+25

✓ DOAJ Verified+15

Total60

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

1.285

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.526

Total Works

236

Total Citations

1,396

2yr Mean Citedness

2.28

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

The Journal of Immunotherapy and Precision Oncology focuses on the application of immunotherapy and targeted therapies in the treatment of various cancers. Recent articles highlight the evolving landscape of cancer treatment, emphasizing precision oncology approaches, the development of novel therapeutic modalities, and the investigation of biomarkers to guide clinical decision-making. The journal covers research on specific cancer types, including prostate, lung, pancreatic, hematologic malignancies, and rare solid tumors, as well as the mechanisms of immune response and resistance in cancer.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

weeks to review

Slow · median is 15 wks

SJR Rank

Top 25% in field

General Information

Country / RegionUnited States

Primary LanguageEnglish

1st Year Published2008

FrequencyQuarterly

StatusActive (last: 2025)

Total Publications236

OA Since2019

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

Review Time~24 weeks

Acceptance Rate—

OA LicenseCC BY, CC BY-NC-ND, Public domain

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

LOCKSSPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Innovative Healthcare Institute

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2666-2345 / 2590-017X

✅

Indexed in a trusted database?

Scopus, DOAJ

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

LOCKSS, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ1

Cancer ResearchQ2

ImmunologyQ2

Immunology and AllergyQ2

Subject Classification

Web of Science Categories

ImmunologyOncology

Scopus Categories

ImmunologyCancer ResearchImmunology and AllergyOncology

Research Topics (OpenAlex)

Cancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsCAR-T cell therapy researchLung Cancer Treatments and MutationsImmunotherapy and Immune ResponsesColorectal Cancer Treatments and StudiesLung Cancer Diagnosis and TreatmentImmune Cell Function and InteractionChronic Lymphocytic Leukemia ResearchPARP inhibition in cancer therapy